U.S. Healthcare Services Stock News

NYSE:COF
NYSE:COFConsumer Finance

A Look At Capital One Financial (COF) Valuation After Mixed Q1 2026 Results And New Quarterly Dividend

Capital One Financial (COF) recently approved a quarterly dividend of $0.80 per share, payable on June 1, 2026, after releasing mixed Q1 2026 results that combined strong revenue trends with higher provisions in its card and consumer businesses. See our latest analysis for Capital One Financial. Despite the recent dividend announcement and ongoing integration of Discover, Capital One Financial's share price is down 25% year to date and 10% over 3 months. Its 3 year total shareholder return of...
NYSE:VFC
NYSE:VFCLuxury

VF Corp (VFC) Net Margin Improvement Challenges Bearish Profitability Narratives

V.F (VFC) has just wrapped up FY 2026 with fourth quarter revenue of US$2.2 billion and a basic EPS loss of US$0.30, capping a trailing twelve months in which revenue reached US$9.6 billion and basic EPS came in at US$0.65 as net margin moved to 2.7% from 0.7% last year. Over recent quarters the company has seen revenue move between US$1.8 billion and US$2.9 billion while quarterly EPS has ranged from a loss of US$0.30 to EPS of US$0.77. This sets up a picture where modest top line progress...
NYSE:APLE
NYSE:APLEHotel and Resort REITs

A Look At Apple Hospitality REIT (APLE) Valuation As Earnings Beat And Dividend Confidence Draw Investor Interest

Apple Hospitality REIT (APLE) has reaffirmed its regular monthly cash dividend of US$0.08 per share, payable on June 15, 2026, a key update for income focused investors monitoring the stock’s recent performance. See our latest analysis for Apple Hospitality REIT. The dividend affirmation comes as the share price trades at US$14.51, with a 30 day share price return of 11.62% and a 1 year total shareholder return of 35.69%, indicating recent momentum supported by earnings and operations...
NYSE:ARCO
NYSE:ARCOHospitality

Arcos Dorados Holdings (ARCO) Margin Gains Challenge Bearish Earnings Decline Narrative

Arcos Dorados Holdings (NYSE:ARCO) opened 2026 with Q1 revenue of US$1.2 billion and basic EPS of US$0.17, while trailing 12 month EPS stood at US$1.11 on total revenue of US$4.8 billion. Over the past year, the company has seen trailing net profit margin improve from 3% to 4.9%, as earnings rose very sharply on a trailing basis and helped compress the trailing P/E multiple to 8.2x against higher industry averages. For investors, the latest quarter keeps the focus firmly on how durable these...
NYSE:BLK
NYSE:BLKCapital Markets

A Look At BlackRock (BLK) Valuation As DOJ And SEC Probe Private Credit Fund Practices

BlackRock (BLK) stock is back in focus after the U.S. Department of Justice and the SEC opened investigations into valuation practices at its TCP Capital Corp private credit fund, increasing attention on potential legal and operational risks. See our latest analysis for BlackRock. The investigation headlines have arrived after a choppy stretch for the stock, with a 7 day share price return that declined 3.65% and a 90 day share price return that declined 2.73%. This comes even though the 1...
NasdaqGS:VTRS
NasdaqGS:VTRSPharmaceuticals

What Viatris (VTRS)'s Fast-Acting Pain Drug Filing and Profit Uptick Means For Shareholders

In May 2026, Viatris Inc. reported first-quarter revenue of US$3,517.0 million and net income of US$176.4 million, and the FDA accepted for review its New Drug Application for MR-107A-02, a fast-acting meloxicam formulation for moderate-to-severe acute pain with a PDUFA goal date of December 27, 2026. The fast-acting meloxicam NDA, backed by Phase 3 data showing pain relief and reduced opioid use, highlights Viatris’ push into higher-value, clinically differentiated medicines alongside its...
NYSE:KKR
NYSE:KKRCapital Markets

Assessing KKR (KKR) After Recent Share Price Weakness And Private Markets Headwinds

Wondering whether KKR at around US$94.76 is starting to look attractively priced, or if the recent weakness is a warning sign for your portfolio? The stock is down 4.8% over the past week, 9.3% over the past month, 26.5% year to date and 19.3% over the past year. The 3 year and 5 year returns stand at 90.9% and 77.5% respectively. Recent coverage around private markets, fundraising conditions and deal activity has kept attention on global alternative asset managers such as KKR. This...
NasdaqGS:VRNS
NasdaqGS:VRNSSoftware

A Look At Varonis Systems (VRNS) Valuation As Profitability And Efficiency Concerns Pressure Sentiment

Conference spotlight and investor concerns Varonis Systems (VRNS) heads into its May 19 appearance at the J.P. Morgan Global Technology, Media and Communications Conference with investor sentiment already under pressure from efficiency and profitability concerns. Recent commentary has focused on Varonis’s slower long term revenue growth compared with software peers, a customer acquisition cost payback period that appears unfavorable, and a GAAP operating margin that has been moving lower...
NYSE:PPL
NYSE:PPLElectric Utilities

How PPL's Dividend, Equity Shelves and Grid Spend Plan Will Impact PPL (PPL) Investors

PPL Corporation recently declared a past quarterly dividend of US$0.2850 per share and closed a US$246.59 million ESOP-related shelf registration while filing a new US$563.43 million common stock shelf, alongside reaffirming its 2026 ongoing earnings guidance and reporting higher first-quarter 2026 sales and net income versus a year earlier. These moves, combined with a US$23.00 billion infrastructure investment plan and fresh long-term financing, underline PPL’s intent to fund large-scale...
NasdaqGS:FLEX
NasdaqGS:FLEXElectronic

Flex (FLEX) EPS Climb To US$0.67 Tests Bullish Growth Narratives

Flex (FLEX) has just closed out FY 2026 with fourth quarter revenue of US$7.5b and basic EPS of US$0.67, set against trailing 12 month revenue of US$27.9b and EPS of US$2.37. Over recent quarters, the company has seen revenue move from US$6.4b in Q4 FY 2025 to US$7.5b in Q4 FY 2026. Quarterly EPS has ranged from US$0.51 to US$0.67, giving you a clear picture of the recent top line and per share earnings profile as a base case for the latest release. With trailing net profit margins around...
NYSE:ENS
NYSE:ENSElectrical

EnerSys (ENS) Margin Compression Challenges Bullish Earnings Expansion Narrative In FY 2026 Results

EnerSys (ENS) has just wrapped up FY 2026 with fourth quarter revenue of US$987.9 million and basic EPS of US$2.11. This makes it a key update for investors tracking how the business is converting sales into earnings. Over recent periods, the company has seen quarterly revenue move between US$893.0 million and US$987.9 million, while basic EPS has ranged from US$1.48 to US$2.45. This gives you a clear view of how the top line and per share earnings have tracked together into the latest print...
NYSE:MDT
NYSE:MDTMedical Equipment

Medtronic’s SPR Therapeutics Deal Broadens Chronic Pain Neuromodulation Story

Medtronic (NYSE:MDT) has announced an agreement to acquire SPR Therapeutics. The deal brings SPR’s FDA cleared SPRINT PNS System into Medtronic’s chronic pain management portfolio. The transaction is aimed at expanding Medtronic’s Neuromodulation business with temporary peripheral nerve stimulation technology. For you as an investor, this move remains within Medtronic’s core line of business in medical devices for chronic conditions, including pain. Chronic pain is a large treatment area...
NYSE:SE
NYSE:SEMultiline Retail

The Bull Case For Sea (SE) Could Change Following Q1 2026 Earnings Beat And Share Buybacks – Learn Why

In the first quarter of 2026, Sea Limited reported revenue of US$7,097.49 million and net income of US$427.94 million, while also completing a share repurchase of 1,916,234 shares for US$182.93 million under its buyback plan announced in November 2025. These results underscore the growing contribution of Shopee, Monee, and Garena, as Sea pairs earnings expansion with active capital returns through measured share buybacks. We'll now examine how Sea's strong first-quarter performance,...
NasdaqGS:TEM
NasdaqGS:TEMLife Sciences

How Investors Are Reacting To Tempus AI (TEM) Expanding Its AI‑Driven Oncology And Alzheimer’s Toolkit

Earlier this month, Tempus AI completed a US$400,000,000 zero‑coupon, callable and convertible senior note offering due 2032, expanded its AI‑driven clinical trial initiative with Bristol Myers Squibb across oncology and Alzheimer’s programs, and clinically launched the ArteraAI Prostate Test for metastatic hormone‑sensitive prostate cancer on its platform. Together, the deeper Bristol Myers Squibb collaboration and the ArteraAI Prostate Test launch underscore Tempus AI’s push to turn its...
NasdaqCM:EOSE
NasdaqCM:EOSEElectrical

A Look At Eos Energy Enterprises (EOSE) Valuation After Frontier Power Battery Storage Deal

Shares of Eos Energy Enterprises (EOSE) moved after Frontier Power USA agreed to acquire a 480 MWh battery storage project portfolio that will use Eos Z3 systems, the first deployment under their 2 GWh capacity reservation agreement. See our latest analysis for Eos Energy Enterprises. The 14.91% 1‑day share price return to US$8.17 adds to a 16.22% 30‑day share price gain, although the stock is still down 37.01% year to date while the 3‑year total shareholder return is a little over 3x. If...
NYSE:JPM
NYSE:JPMBanks

JPMorgan Chase Weighs AI Workforce Shift Interest Rate Risks And Governance

JPMorgan Chase (NYSE:JPM) is reshaping its workforce as CEO Jamie Dimon flags a shift away from traditional banking roles toward AI specialists. Dimon has also cautioned that future interest rates could be higher than some market participants expect, highlighting risks for banks and borrowers. At the latest shareholder meeting, proposals for greater lobbying disclosure and for splitting the CEO and chair roles were raised but did not pass. JPMorgan Chase is one of the largest global banks,...
NasdaqGS:NDSN
NasdaqGS:NDSNMachinery

Nordson (NDSN) Margin Strength In Q2 2026 Reinforces Bullish Profitability Narratives

Nordson (NDSN) has just posted its Q2 2026 numbers, reporting revenue of US$740.8 million and basic EPS of US$2.10, alongside trailing 12 month EPS of US$9.43 and net income of US$528.1 million that tie into the 18.3% earnings growth shown in the data. Over the past year, revenue on a trailing 12 month basis has moved from US$2.70 billion in Q2 2025 to US$2.90 billion in Q2 2026. Quarterly EPS ranged from US$1.98 in Q2 2025 to US$2.10 in the latest quarter, framing the current release within...
NasdaqGS:MELI
NasdaqGS:MELIMultiline Retail

Michael Burry Backs MercadoLibre Margin Reset With Bigger Long Term Bet

Michael Burry has significantly increased his stake in MercadoLibre after the recent share price pullback and Q1 2026 margin compression. The move comes as many investors concentrate on near term profitability pressure and wider market concerns. Burry's larger position reflects his conviction in MercadoLibre's long term value and business model. For investors tracking NasdaqGS:MELI, this comes at a time when the stock is trading around $1,677.9 and is down 15.0% year to date and 35.6% over...
NYSE:EG
NYSE:EGInsurance

Everest Group (EG) Valuation Check After Recent Pullback And Ongoing Reinsurance Growth Story

Recent performance and scale check for Everest Group (EG) Everest Group (EG) has drawn investor attention after a recent pullback of about 0.5% in the latest session, while the stock is up around 1.9% over the past month and 4.1% in the past 3 months. At a last close of US$356.45 and a market value near US$14.2b, the Bermuda based insurer and reinsurer sits in the large cap bracket. It offers investors exposure to both insurance and reinsurance segments across multiple regions. The business...
NasdaqGS:PERI
NasdaqGS:PERIMedia

Perion Network (PERI) Q1 Loss Challenges Bullish Margin Recovery Narratives

Perion Network (NasdaqGS:PERI) opened 2026 with Q1 revenue of US$90.4 million and a basic EPS loss of US$0.26, as the stock trades around US$8.84. The company has seen quarterly revenue move from US$89.3 million in Q1 2025 to US$137.1 million in Q4 2025 and then to US$90.4 million in Q1 2026. Basic EPS has ranged from a loss of US$0.19 in Q1 2025 to a profit of US$0.20 in Q4 2025 before returning to a loss of US$0.26 this quarter. This sets up a results season in which margins and the path...
NYSE:LEN
NYSE:LENConsumer Durables

Assessing Lennar (LEN) After Softer Results And Quarterra Asset Sales Raise Fresh Valuation Questions

Recent updates around Lennar (LEN) have focused on softer quarterly results and a shrinking backlog. Investors are also watching asset sales at Quarterra, where Lennar holds a minority stake, for clues on portfolio positioning. See our latest analysis for Lennar. The share price has slipped over the past quarter, with a 90 day share price return of down 23.7%, and the 1 year total shareholder return of down 14.1% points to weaker longer term momentum despite a recent 7 day share price return...
NasdaqGS:MDLN
NasdaqGS:MDLNMedical Equipment

Medline Expands AutoStore Network As Shares Trade Below Analyst Targets

Medline (NasdaqGS:MDLN) is expanding its automated warehousing footprint with a new AutoStore system at its Aurora, Colorado distribution center. The Aurora deployment is the company's 24th AutoStore site and is intended to support rising regional demand and supply chain modernization. Medline, a large player in medical supplies and healthcare distribution, is leaning further into warehouse automation as logistics pressures and customer expectations remain high across the sector. The new...
NasdaqGS:HLNE
NasdaqGS:HLNECapital Markets

Assessing Hamilton Lane (HLNE) Valuation After A Steep Share Price Pullback

Hamilton Lane stock performance catch-up Hamilton Lane (HLNE) has drawn investor attention after recent price volatility, with the stock down 17% over the past month and 17% over the past 3 months, alongside a 35% decline year to date. See our latest analysis for Hamilton Lane. The recent weakness, with a 30 day share price return of down 16.5% and year to date share price return of down 35.2%, contrasts with a three year total shareholder return of 41.4%. This suggests momentum has faded...
NasdaqGS:INVA
NasdaqGS:INVAPharmaceuticals

Innoviva Board Shakeup Puts Governance And Valuation In Focus

Innoviva (NasdaqGS:INVA) announced the resignation of two directors from its board. Josephine Linden has been appointed as an independent director and will serve on the Audit Committee. The departing directors intend to focus on a portfolio company in which Innoviva has invested. For investors watching Innoviva, the boardroom is now an important part of the story. The company last closed at $22.2, with the stock up 11.7% year to date and 18.0% over the past year. Over a longer horizon,...